ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STRM Streamline Health Solutions Inc

0.2891
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Streamline Health Solutions Inc NASDAQ:STRM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.2891 0.271 0.32 0 01:00:00

Initial Statement of Beneficial Ownership (3)

25/10/2019 11:51pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ferayorni Justin John

2. Date of Event Requiring Statement (MM/DD/YYYY)
10/16/2019 

3. Issuer Name and Ticker or Trading Symbol

STREAMLINE HEALTH SOLUTIONS INC. [STRM]

(Last)        (First)        (Middle)

5050 AVENIDA ENCINAS, SUITE 360

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          ___X___ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)

(Street)

CARLSBAD, CA 92008      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $0.01 par value 4305882 (1)(2)D (1)(2) 
Common Stock, $0.01 par value 33252 (3)D (3) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) The reported securities represent 3,598,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 707,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2, Tamarack Advisers, LP is the investment adviser to Fund 1 and Fund 2, and Justin J. Ferayorni is the sole managing member of both Tamarack Capital Management, LLC and Tamarack Capital GP, LLC. Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
(2) Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Mr. Ferayorni disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.
(3) The reported securities represent shares owned directly by Mr. Ferayorni.

Remarks:
Mr. Ferayorni is the sole owner of the reported entities, other than Tamarack Global Healthcare Fund, L.P. and Tamarack Global Healthcare Fund QP, L.P., and signed this form on behalf of himself, each of the other reporting entities, and as the managing member of the general partner of Tamarack Global Healthcare Fund, L.P. and Tamarack Global Healthcare Fund QP, L.P.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Ferayorni Justin John
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD, CA 92008

X

Tamarack Capital GP, LLC
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD, CA 92008

X

Tamarack Advisers, LP
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD, CA 92008

X

Tamarack Capital Management, LLC
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD, CA 92008

X

Tamarack Global Healthcare Fund, L.P.
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD, CA 92008

X

Tamarack Global Healthcare Fund QP, L.P.
5050 AVENIDA ENCINAS
SUITE 360
CARLSBAD, CA 92008



Member of a group

Signatures
Justin J. Ferayorni10/25/2019
**Signature of Reporting PersonDate

1 Year Streamline Health Soluti... Chart

1 Year Streamline Health Soluti... Chart

1 Month Streamline Health Soluti... Chart

1 Month Streamline Health Soluti... Chart

Your Recent History

Delayed Upgrade Clock